Ship GenAI with Evidence, Not Instinct
GenAI products shouldn’t scale on demos or instinct. Leaders need the evidence, standards, and validation discipline to make release decisions with confidence.
Mind the Gap!
Too many teams try to scale GenAI before they can prove it’s ready for production. Test coverage stays uneven, acceptance criteria drift, and release confidence depends too much on opinion.
Key Evaluation & Validation Questions
- Are we generating enough evidence to support confident GenAI release decisions?
- Where could weak test assets, unclear acceptance criteria, or thin coverage create release risk or delay?
- Are we using evaluation evidence to improve the product, or relying on demos and instinct?
The Bottom-Line
Without strong evaluation evidence, release confidence weakens and scale gets riskier.
Turn Evaluation Gaps Into Release Confidence
We pinpoint the evaluation and validation gaps that matter most and build a practical plan to strengthen evidence, standards, and release discipline.
Launch Pad
Assess Your Readiness
Weeks 1–2
Align the team
- Identify key stakeholders
- Explore what “good” looks like
- Explore Real-World Use Cases
Assess current state
- Review Key Competencies
- Assess Your Readiness
- Add Comments for Context
Define readiness gaps
- Define Group Readiness
- Identify Mis-Alignment
- Capture Group Themes
Mission Control & Lift-Off
Build Your
Plan
Plan
Weeks 3–4
Prioritize the gaps
- Understand High-Impact Gaps
- Explore Gap Closure Options
- Prioritize For Impact & Effort
Build the roadmap
- Define Key Steps
- Align on Ownership
- Define Target Timeline
Define success measures
- Committed Target
- Stretch Goals
- Controls
Accelerate
Accelerate Your Momentum
Weeks 5–12
Execute priority moves
- Execute your plan
- Mitigate Risks
- Validate Your Impact
Drive adoption & change
- Identify Stakeholders
- Communicate Changes
- Action Feedback
Review impact & what's next
- Re-baseline Readiness
- Select Next Gaps
- Update your readiness plan
Outcomes you can expect
Clarity
See which evidence, coverage, and evaluation gaps matter most.
Alignment
Align teams on the standards required for confident GenAI releases.
Focus
Prioritize the gaps most likely to slow releases or weaken quality.
Readiness
Build the evidence foundation needed to ship, learn, and improve faster.
Impact
Increase release confidence while reducing delay, drift, and avoidable risk.
Release confidence improves when evidence replaces opinion.
Frequently Asked Questions
1. Overview & Fit
2. Scope & Deliverables
3. Process & Timing
4. Participants & Ways of Working
5. Outcomes & Next Steps
- Who is this Product-Level Evaluation & Validation readiness accelerator for?
It’s built for product leaders, AI leads, engineering leaders, QA leaders, research teams, and platform owners responsible for proving GenAI quality before and after release. It’s especially useful when teams are making high-stakes launch or scaling decisions without enough confidence in the evidence. - When should we run a Product-Level Evaluation & Validation readiness accelerator?
Assess it before weak evaluation practices turn into release risk, rework, or low-confidence product decisions. Teams often use this accelerator when GenAI is approaching launch, when quality debates are slowing progress, or when production signals show the current evidence model isn’t strong enough. - How is this different from normal QA or testing work?
Traditional QA often focuses on expected software behavior and regression coverage. This accelerator looks at whether the organization is ready to evaluate GenAI with stronger datasets, scenarios, criteria, human judgment, and validation routines that reflect how AI products behave in the real world.
- What exactly gets assessed in Product-Level Evaluation & Validation readiness?
We assess evaluation strategy, test assets, scenario coverage, acceptance criteria, validation workflows, evidence quality, and the way results inform release and improvement decisions. It identifies where those foundations are still too weak or fragmented to support GenAI at scale. - What inputs and artifacts should we bring into the accelerator?
Helpful inputs include test sets, evaluation criteria, release gates, model scorecards, production signals, known failure patterns, user feedback, QA workflows, and examples of how quality decisions are made today. These materials help reveal where evidence is strong and where teams are still relying too heavily on judgment alone. - What will we receive at the end of the accelerator?
You’ll receive a current-state readiness view, a prioritized set of evaluation and validation gaps, and a practical action plan for strengthening how GenAI quality is proven over time. The goal is to leave with clearer priorities for building a more dependable quality discipline.
- How long does the accelerator take?
The accelerator is designed as a 12-week engagement with the first four weeks focused on diagnostic work, readout, and prioritization. The remaining weeks support action planning, guided improvement, and readiness refresh work on the evaluation foundations that matter most. - How do the three phases work in practice?
The first phase identifies the highest-risk evaluation gaps through a diagnostic and evidence review. The second phase aligns leaders on priorities and actions, and the third phase helps teams strengthen the highest-leverage validation practices while defining what comes next. - How hands-on is the 12-week period?
It’s practical and collaborative rather than theoretical. We work with the right leaders and teams to review how quality is assessed today, shape stronger evaluation routines, and support progress on the changes that most affect release confidence and product improvement.
- Which teams should participate?
The right mix usually includes product, engineering, QA, AI or applied science, platform, and any leaders responsible for release decisions or measurement. The goal is to involve the people who shape how GenAI quality is judged and what evidence counts as good enough. - How much time should leaders and working teams expect to commit?
Leaders should expect time for kickoff, readouts, and alignment on quality priorities and release-risk decisions. Working teams should expect focused time for diagnostic input, workflow review, and action planning, with the exact level depending on how central GenAI is to the product experience. - How will the right teams work together during the accelerator?
The accelerator creates a clear picture of how product, engineering, QA, and AI teams contribute to stronger evaluation and validation. That helps teams move from fragmented quality judgments to a more coordinated discipline for proving readiness and improving over time.
- What changes when Product-Level Evaluation & Validation readiness improves?
Teams gain a clearer view of which evidence gaps matter most, where weak validation is creating release risk, and how to build a stronger quality discipline around GenAI. That makes it easier to launch with more confidence and improve based on stronger signals. - How quickly can we act on the findings?
Most teams can begin acting on the findings quickly because the accelerator is designed to produce a practical, prioritized action plan. Some improvements are immediate changes to evaluation criteria, test coverage, or review routines, while others shape broader quality strategy and governance decisions. - What should we do after the readiness assessment is complete?
Act on the findings by strengthen evaluation strategy, validation workflows, release criteria, and evidence standards where they matter most. The strongest teams revisit readiness as new use cases emerge, models change, and the bar for GenAI quality keeps rising.
Strengthen Release Confidence